Altos Labs Archives

Weekly reads: Altos Labs aging supplements pub, destructive NIH cuts, FDA warning, HSCs

February 9, 2025 / Professor Paul Knoepfler, Ph.D. / 3 Comments

When I think of so-called aging supplements, visions of snake oil dance in my head. Possible benefits of supplements more generally have mostly not held up to long-term research. Supplements have risks too and so do purported longevity supplements. These pills claiming to fight aging are more in the realm of stem cell supplements that […]

Weekly reads: Altos Labs aging supplements pub, destructive NIH cuts, FDA warning, HSCs Read More »

Altos Labs: mission, leadership, jobs, & CIRM

April 12, 2022 / Professor Paul Knoepfler, Ph.D. / 3 Comments

At the beginning of the year I wrote about a new kind of biotech called Altos Labs. It’s very different in some ways from other institutions. I find it an intriguing research entity. Where do things stand now with Altos Labs a few months later? More information, new ideas, and questions have popped up in the

Altos Labs: mission, leadership, jobs, & CIRM Read More »

Recommended reads: senolytics, cow iPS cells, big CIRM royalty

January 30, 2022 / Professor Paul Knoepfler, Ph.D. / 1 Comment

When we hear the word senile we might think stereotypically of an older person who has cognitive impairment, but some argue that senility can apply to cells too as they age and that such cells can be targeted by drugs called senolytics. Unfortunately, the supplements industry has picked up on this idea to sell iffy

Altos Labs

Weekly reads: Altos Labs aging supplements pub, destructive NIH cuts, FDA warning, HSCs

Altos Labs: mission, leadership, jobs, & CIRM

Recommended reads: senolytics, cow iPS cells, big CIRM royalty

Subscribe to Our Newsletter